544529 — Aptus Pharma Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹1.25bn
- IN₹1.31bn
- IN₹465.75m
Annual cashflow statement for Aptus Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2023 March 31st | 2024 March 31st | 2025 March 31st | 2026 March 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PRESS |
| Standards: | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | 2.95 | 11.2 | 42 | 46.2 |
| Depreciation | ||||
| Non-Cash Items | 1.43 | 2.14 | 3.89 | 24 |
| Other Non-Cash Items | ||||
| Changes in Working Capital | -8 | -37.2 | -66.9 | -143 |
| Change in Accounts Receivable | ||||
| Change in Inventories | ||||
| Change in Other Assets | ||||
| Change in Accounts Payable | ||||
| Change in Other Liabilities | ||||
| Other Operating Cash Flow | ||||
| Cash from Operating Activities | -1.81 | -21.7 | -18.4 | -68.6 |
| Capital Expenditures | -3.53 | -3.3 | -6.22 | -21.9 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | — | 0.252 | 0.77 | -41.8 |
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -3.53 | -3.04 | -5.45 | -63.7 |
| Financing Cash Flow Items | -1.43 | -2.39 | 9.34 | -7.98 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Net Issuance / Retirement of Debt | ||||
| Cash from Financing Activities | 8.1 | 28.6 | 66.8 | 90.4 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | 2.76 | 3.78 | 43 | -41.9 |